Insys Therapeutics, Inc. 4
4 · Insys Therapeutics, Inc. · Filed Apr 20, 2017
Insider Transaction Report
Form 4
Motahari Saeed
DirectorPresident & CEO
Transactions
- Award
Employee Stock Option (right to buy)
2017-04-17+325,000→ 325,000 totalExercise: $10.57Exp: 2027-04-16→ Common Stock (325,000 underlying) - Award
Restricted Stock Units
2017-04-17+33,000→ 33,000 total→ Common Stock (33,000 underlying)
Footnotes (3)
- [F1]The option vests in 48 equal monthly installments and will be fully vested and exercisable on April 17, 2021.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F3]Represents shares issuable upon the vesting of restricted stock units ("RSUs") awarded to the Reporting Person on April 17, 2017. The RSUs vest in 3 equal annual installments beginning on April 17, 2018 and will be fully vested on April 17, 2020, in all cases so long as there has been no break in the Reporting Person's continuous service through such date.